HESI Global’s Developmental and Reproductive Toxicology (DART) Committee is pleased to share a newly published paper that proposes a shift from routinely excluding pregnant and breastfeeding individuals from clinical trials to a more proactive, evidence-based inclusion strategy.
Nonclinical Considerations for Support of Pregnancy and Lactation in Clinical Trials
Birth Defects Research, 2026